{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:35:38Z","timestamp":1787945738284,"version":"build-2784847793"},"reference-count":63,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jmsacl.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T12:45:49Z","timestamp":1676637949000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projects"],"prefix":"10.21627","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9075-4951","authenticated-orcid":false,"given":"S.","family":"Rischke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hahnefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5918-3249","authenticated-orcid":false,"given":"B.","family":"Burla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-1295","authenticated-orcid":false,"given":"R.","family":"Gurke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-009X","authenticated-orcid":false,"given":"T.J.","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"key":"10.1016\/j.jmsacl.2023.02.003_b0005","doi-asserted-by":"crossref","unstructured":"Bhandari, Mohit M.D., M.SC., F.R.C.S.C.*, Schemitsch, Emil H. M.D., F.R.C.S.C.\u2020, Planning a Randomized Clinical Trial - An Overview, Techniques in Orthopaedics 19 (2004) 66\u201371.","DOI":"10.1097\/00013611-200406000-00004"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0010","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2018.6360","article-title":"Randomization in Clinical Trials: Permuted Blocks and Stratification","volume":"219","author":"Broglio","year":"2018","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/clpt.2011.207","article-title":"Blinding in randomized clinical trials: imposed impartiality","volume":"90","author":"Hr\u00f3bjartsson","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5858\/arpa.2012-0198-RA","article-title":"Understanding sources of bias in diagnostic accuracy studies","volume":"137","author":"Schmidt","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-021-03450-0","article-title":"From bedside to bench-practical considerations to avoid pre-analytical pitfalls and assess sample quality for high-resolution metabolomics and lipidomics analyses of body fluids","author":"Lehmann","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1515\/CCLM.2011.600","article-title":"Preanalytical quality improvement: from dream to reality","volume":"49","author":"Lippi","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4155\/bio.15.244","article-title":"Bioanalytical techniques in nontargeted clinical lipidomics","volume":"8","author":"Hy\u00f6tyl\u00e4inen","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jbiosc.2017.11.011","article-title":"Differences in metabolite profiles caused by pre-analytical blood processing procedures","volume":"125","author":"Nishiumi","year":"2018","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1373\/clinchem.2013.211979","article-title":"Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling","volume":"60","author":"Kamlage","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0050","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00216-012-6039-y","article-title":"Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry","volume":"403","author":"Vuckovic","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0055","first-page":"636","article-title":"Biochimica et biophysica acta","volume":"62","author":"Liebisch","year":"2017","journal-title":"BBA"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0060","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.4155\/bio.14.119","article-title":"Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues","volume":"6","author":"Naz","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0065","first-page":"433","article-title":"Haemolysis index for the screening of intravascular haemolysis: a novel diagnostic opportunity?","volume":"16","author":"Lippi","year":"2018","journal-title":"Blood Transfus."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0070","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1373\/clinchem.2017.277905","article-title":"Quality Control of Serum and Plasma by Quantification of (4E,14Z)-Sphingadienine-C18-1-Phosphate Uncovers Common Preanalytical Errors During Handling of Whole Blood","volume":"64","author":"Liu","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10858-011-9574-5","article-title":"Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks","volume":"51","author":"Fliniaux","year":"2011","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0080","doi-asserted-by":"crossref","unstructured":"S. Cuhadar, M. Koseoglu, A. Atay, A. Dirican, The effect of storage time and freeze-thaw cycles on the stability of serum samples, Biochem. Med. (Zagreb) 23 (2013) 70\u201377. 10.11613\/bm.2013.009.","DOI":"10.11613\/BM.2013.009"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2016.01.058","article-title":"Thawing as a critical pre-analytical step in the lipidomic profiling of plasma samples: New standardized protocol","volume":"912","author":"Pizarro","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-021-01828-w","article-title":"Challenges in LC-MS-based metabolomics for Alzheimer's disease early detection: targeted approaches versus untargeted approaches","volume":"17","author":"Reveglia","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0095","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-021-24984-y","article-title":"Quality control requirements for the correct annotation of lipidomics data","volume":"12","author":"K\u00f6feler","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1194\/jlr.D119000393","article-title":"Shared reference materials harmonize lipidomics across MS-based detection platforms and laboratories","volume":"61","author":"Triebl","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fmars.2017.00405","article-title":"High-Resolution Liquid Chromatography Tandem Mass Spectrometry Enables Large Scale Molecular Characterization of Dissolved Organic Matter","volume":"4","author":"Petras","year":"2017","journal-title":"Front. Mar. Sci."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0110","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jssc.200900659","article-title":"Applications of HILIC for targeted and non-targeted LC\/MS analyses in drug discovery","volume":"33","author":"Onorato","year":"2010","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0115","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1039\/C6AN01753C","article-title":"Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry","volume":"141","author":"Zhou","year":"2016","journal-title":"Analyst"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0120","doi-asserted-by":"crossref","first-page":"e0207082","DOI":"10.1371\/journal.pone.0207082","article-title":"Development, characterization and comparisons of targeted and non-targeted metabolomics methods","volume":"13","author":"Ribbenstedt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0125","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1021\/acs.jproteome.2c00297","article-title":"High Throughput LC-MS Platform for Large Scale Screening of Bioactive Polar Lipids in Human Plasma and Serum","volume":"21","author":"Munjoma","year":"2022","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0130","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s11306-015-0818-3","article-title":"Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples","volume":"11","author":"Jonsson","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11306-020-01728-5","article-title":"Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners","volume":"16","author":"Evans","year":"2020","journal-title":"Metabolomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmsacl.2021.06.001","article-title":"A data-driven approach for the detection of internal standard outliers in targeted LC-MS\/MS assays","volume":"20","author":"Wilkes","year":"2021","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/pmic.200700694","article-title":"Comparative LC-MS: a landscape of peaks and valleys","volume":"8","author":"America","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0150","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4155\/bio.14.71","article-title":"Reasons for calibration standard curve slope variation in LC-MS assays and how to address it","volume":"6","author":"Zhao","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jpba.2007.03.003","article-title":"System suitability in bioanalytical LC\/MS\/MS","volume":"44","author":"Briscoe","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11306-018-1367-3","article-title":"Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies","volume":"14","author":"Broadhurst","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fgene.2014.00354","article-title":"Stratified randomization controls better for batch effects in 450K methylation analysis: a cautionary tale","volume":"5","author":"Buhule","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.trac.2016.06.011","article-title":"Increasing selectivity and coverage in LC-MS based metabolome analysis","volume":"82","author":"Ortmayr","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123069","article-title":"Current state-of-the-art of separation methods used in LC-MS based metabolomics and lipidomics","volume":"1188","author":"Harrieder","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0180","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1194\/jlr.S087163","article-title":"MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines","volume":"59","author":"Burla","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0185","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1007\/s00216-015-8681-7","article-title":"Non-target screening with high-resolution mass spectrometry: critical review using a collaborative trial on water analysis","volume":"407","author":"Schymanski","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0190","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.trac.2016.07.004","article-title":"Data analysis strategies for targeted and untargeted LC-MS metabolomic studies: Overview and workflow","volume":"82","author":"Gorrochategui","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0195","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.4155\/bio.12.212","article-title":"A QC approach to the determination of day-to-day reproducibility and robustness of LC-MS methods for global metabolite profiling in metabonomics\/metabolomics","volume":"4","author":"Gika","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0205","doi-asserted-by":"crossref","first-page":"16369","DOI":"10.1021\/acs.analchem.1c02826","article-title":"Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring","volume":"93","author":"Ghorasaini","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0210","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10462-019-09709-4","article-title":"Missing value imputation: a review and analysis of the literature (2006\u20132017)","volume":"53","author":"Lin","year":"2020","journal-title":"Artif. Intell. Rev."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0215","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41598-017-19120-0","article-title":"Missing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data","volume":"8","author":"Wei","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11306-016-1030-9","article-title":"Non-targeted UHPLC-MS metabolomic data processing methods: a comparative investigation of normalisation, missing value imputation, transformation and scaling","volume":"12","author":"Di Guida","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0225","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2116\/analsci.28.801","article-title":"Quantile normalization approach for liquid chromatography-mass spectrometry-based metabolomic data from healthy human volunteers","volume":"28","author":"Lee","year":"2012","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0230","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11306-016-0972-2","article-title":"A batch correction method for liquid chromatography-mass spectrometry data that does not depend on quality control samples","volume":"12","author":"Rusilowicz","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0235","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0245","doi-asserted-by":"crossref","first-page":"15534","DOI":"10.1038\/s41598-020-72664-6","article-title":"How to do quantile normalization correctly for gene expression data analyses","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0250","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/bimj.201700294","article-title":"Covariate selection strategies for causal inference: Classification and comparison","volume":"61","author":"Witte","year":"2019","journal-title":"Biom. J."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0255","doi-asserted-by":"crossref","first-page":"e1700448","DOI":"10.1002\/pmic.201700448","article-title":"Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics","volume":"19","author":"Srivastava","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0260","doi-asserted-by":"crossref","unstructured":"Breimann L., Statistical modelin: The two cultures (with comments and a rejoinder by the author), Statistical Science 16 199\u2013231.","DOI":"10.1214\/ss\/1009213726"},{"issue":"4","key":"10.1016\/j.jmsacl.2023.02.003_b0265","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/bimj.201300226","article-title":"Machine learning versus statistical modeling","volume":"56","author":"Boulesteix","year":"2014","journal-title":"Biom. J."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0270","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41584-021-00708-w","article-title":"An introduction to machine learning and analysis of its use in rheumatic diseases","volume":"17","author":"Kingsmore","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0275","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.nic.2020.08.004","article-title":"Machine Learning Algorithm Validation: From Essentials to Advanced Applications and Implications for Regulatory Certification and Deployment","volume":"30","author":"Maleki","year":"2020","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0280","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.aca.2020.10.038","article-title":"Multi-omics integration in biomedical research - A metabolomics-centric review","volume":"1141","author":"W\u00f6rheide","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11306-018-1404-2","article-title":"A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer","volume":"14","author":"Long","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0290","unstructured":"Vladimir Tolstikov, A. James Moser, Rangaprasad Sarangarajan, Niven R. Narain and Michael A. Kiebish, Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0295","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s12551-021-00849-y","article-title":"Human disease biomarker panels through systems biology","volume":"13","author":"Smith","year":"2021","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0300","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1038\/s41596-021-00566-6","article-title":"Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation","volume":"16","author":"Nakayasu","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8040059","article-title":"A Framework for Development of Useful Metabolomic Biomarkers and Their Effective Knowledge Translation","volume":"8","author":"Marchand","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.jmsacl.2023.02.003_b0310","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1373\/clinchem.2016.254649","article-title":"Waste, Leaks, and Failures in the Biomarker Pipeline","volume":"63","author":"Ioannidis","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2023.02.003_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100138","article-title":"Recommendations for good practice in MS-based lipidomics","volume":"62","author":"K\u00f6feler","year":"2021","journal-title":"J. Lipid Res."}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X2300010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X2300010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:37Z","timestamp":1767770557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X2300010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":63,"alternative-id":["S2667145X2300010X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2023.02.003","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projects","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}